Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...
Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi.
The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...
The European Union's drugs regulator said on Friday it concluded a review into the safety of Eisai and Biogen's Alzheimer's ...
Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...
The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its ...
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
Alzheimer’s advocates are pushing for changes that would make testing and medication readily available and easier to afford.
The European Commission had requested the committee consider new data on the drug that became available after it had adopted its positive opinion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback